Outset Medical, Inc.

Outset Medical, Inc.

NNASDAQ:OM
3.39
USD
-0.34
(-9.12%)
-3.86EPS
56.62MMarket Cap
Feb 17Next Earn

Total Valuation

USD

As of September 30, 2026, Outset Medical, Inc. carries a market capitalization of 56.62M, placing it among publicly traded companies globally. Its enterprise value stands at 24.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap56.62M
Enterprise Value24.77M

Important Dates

Outset Medical, Inc.'s next confirmed earnings release is scheduled for February 17, 2027.

Earnings Date2/17/2027

Share Statistics

As of September 30, 2026, Outset Medical, Inc. has 18.87M shares outstanding.

Shares Outstanding18.87M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 0.45, and the price-to-book ratio stands at 0.68.

PS Ratio0.45
PB Ratio0.68
P/TBV Ratio0.68
P/FCF Ratio-1.29
P/OCF Ratio-1.30

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 0.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 24.77M versus a market cap of 56.62M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.20

Financial Position

As of September 30, 2026, Outset Medical, Inc. maintains a current ratio of 4.86, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 125.76, indicating elevated leverage, while an interest coverage ratio of -4.33 demonstrates limited ability to service its debt obligations.

Current Ratio4.86
Quick Ratio3.76
Debt / Equity125.76
Debt / EBITDA-1.76
Interest Coverage-4.33

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Outset Medical, Inc. posted a negative return on equity (ROE) of -64.14, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -28.03, reflecting losses generated across the asset base. The company generates approximately 393,445.16 in revenue per employee across its workforce of 310.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.50 indicates how many times Outset Medical, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-64.14
Return on Assets (ROA)-28.03
Revenue Per Employee393,445.16
Employee Count310.00
Inventory Turnover1.50

Taxes

USD

Over the twelve months ended September 30, 2026, Outset Medical, Inc. recorded 685,000.00 in income tax expense. The company reported a pretax loss of -70.45M and -71.14M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax685,000.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Outset Medical, Inc.'s stock has declined approximately 27.56% over the past 52 weeks. The 50-day moving average sits at 3.75, while the 200-day moving average is 4.09.

52-Week Price Change-27.56%
50-Day Moving Average3.75
200-Day Moving Average4.09

Income Statement

USD

Over the twelve months ended September 30, 2026, Outset Medical, Inc. generated 121.97M in revenue and converted that into -71.14M in net income, yielding earnings per share of -3.86. EBITDA reached -59.52M, while operating income came in at -62.49M.

Revenue121.97M
Gross Profit51.28M
Operating Income-62.49M
Pretax Income-70.45M
Net Income-71.14M
EBITDA-59.52M
EBIT-62.49M
Earnings Per Share (EPS)-3.86

Balance Sheet

USD

As of September 30, 2026, Outset Medical, Inc. holds 136.63M in cash and equivalents against 104.78M in total debt, resulting in a net debt position of 64.43M. Total book value stands at 83.31M, with working capital of 171.77M providing operational flexibility.

Cash & Cash Equivalents136.63M
Total Debt104.78M
Net Debt64.43M
Equity (Book Value)83.31M
Book Value Per Share4.41
Working Capital171.77M

Cash Flow

USD

Outset Medical, Inc. produced -42.38M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -508,000.00 in capital expenditures, free cash flow totaled -42.89M - equivalent to -2.33 per share.

Operating Cash Flow-42.38M
Capital Expenditures-508,000.00
Free Cash Flow-42.89M
FCF Per Share-2.33

Margins

Over the twelve months ended September 30, 2026, Outset Medical, Inc. posted a gross margin of 42.04, reflecting its pricing power and cost economics. The operating margin of -51.24 and net profit margin of -58.33 provide insight into operational efficiency.

Gross Margin42.04
Operating Margin-51.24
Pretax Margin-57.76
Profit Margin-58.33
EBITDA Margin-48.80

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -77.65: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.63, meaning Outset Medical, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-0.63
FCF Yield-77.65

Stock Splits

Outset Medical, Inc.'s most recent stock split took place on March 20, 2025 with a 15:1 split ratio.

Last Split Date3/20/2025
Split Ratio15:1

Scores

As of September 30, 2026, Outset Medical, Inc. has an Altman Z-Score of -6.67, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-6.67